Lucid Diagnostics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
LUCD Nasdaq 3841 https://www.luciddx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Lucid Diagnostics Inc

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - Apr 8th, 2024 12:30 pm
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript - Mar 28th, 2024 1:47 pm
Q4 2023 PAVmed Inc Earnings Call - Mar 28th, 2024 6:00 am
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript - Mar 27th, 2024 4:35 pm
Q4 2023 Lucid Diagnostics Inc Earnings Call - Mar 27th, 2024 4:14 am
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results - Mar 26th, 2024 11:32 pm
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results - Mar 25th, 2024 9:30 pm
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population - Mar 21st, 2024 1:30 pm
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference - Mar 20th, 2024 12:30 pm
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024 - Mar 12th, 2024 12:30 pm
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program - Feb 16th, 2024 10:00 pm
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony - Feb 15th, 2024 12:45 pm
Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors - Feb 8th, 2024 12:45 pm
The 3 Most Undervalued Penny Stocks to Buy in December - Dec 17th, 2023 8:00 pm
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies - Dec 12th, 2023 1:30 pm
PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders - Dec 11th, 2023 2:00 pm
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split - Dec 4th, 2023 9:20 pm
PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript - Nov 20th, 2023 5:44 pm
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript - Nov 16th, 2023 2:07 pm
Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts - Nov 16th, 2023 2:00 pm